US Physical Therapy (USPH) Form 144 Filed for 2,000-Share Sale
Rhea-AI Filing Summary
US Physical Therapy, Inc. (USPH) submitted a Form 144 notifying a proposed sale of 2,000 shares of common stock through UBS Financial Services on the NYSE with an aggregate market value of $165,127.20. The shares were originally acquired as restricted stock grants on 04/01/2020 (3,089 shares acquired) and were paid as compensation on the acquisition date. The filing states there were no securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Full disclosure of proposed sale details including broker, share count, and aggregate market value
- No reported sales by the reporting person in the past three months, as stated in the filing
- Origin of shares disclosed (restricted stock grants acquired 04/01/2020) and payment method (compensation)
Negative
- Insider intends to sell 2,000 shares which will be executed on the NYSE (aggregate value $165,127.20)
- Outstanding share base disclosed (15,200,000) which contextualizes the sale as part of the public float
Insights
TL;DR: Insider plans a modest sale of 2,000 shares filed under Rule 144; filing is routine and adheres to disclosure requirements.
This Form 144 documents a proposed sale by a person who received restricted stock grants on 04/01/2020 and intends to sell 2,000 common shares via UBS on the NYSE with an indicated aggregate market value of $165,127.20. The filing notes no sales in the prior three months and includes the standard representation regarding material adverse information. For investors, this is a compliance disclosure of an intended transaction rather than a corporate operational update.
TL;DR: The notice is procedurally complete and signals an insider liquidity event based on prior compensation awards.
The report identifies the securities as compensation-based restricted stock grants originally recorded on 04/01/2020 and confirms payment was in connection with compensation. The use of a broker and the absence of other recent sales are disclosed. The filing meets Rule 144 notification norms and provides the required seller attestation about undisclosed material information.